Scarica l'app Stockscreener
0.412
3.41%
0.0136
Dopo l'orario di chiusura:
.41
-0.002
-0.49%
Precedente Chiudi:
$0.3984
Aprire:
$0.39
Volume 24 ore:
60,007
Relative Volume:
0.10
Capitalizzazione di mercato:
$5.75M
Reddito:
$294.20K
Utile/perdita netta:
$-12.25M
Rapporto P/E:
-0.0749
EPS:
-5.5
Flusso di cassa netto:
$-10.77M
1 W Prestazione:
+1.90%
1M Prestazione:
+5.86%
6M Prestazione:
-1.90%
1 anno Prestazione:
-75.76%
Intervallo 1D:
$0.39
$0.415
Intervallo di 1 settimana:
$0.39
$0.4151
Portata 52W:
$0.2375
$2.3499
Aethlon Medical Inc Stock (AEMD) Company Profile
Nome
Aethlon Medical Inc
Settore
Industria
Telefono
619-941-0360
Indirizzo
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Confronta AEMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.412 | 5.75M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Aethlon Medical Inc Borsa (AEMD) Ultime notizie
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 22.7% in November - Defense World
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
HC Wainwright Reaffirms Buy Rating for Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Maxim retains hold on Aethlon Medical shares amid clinical progress By Investing.com - Investing.com UK
Aethlon Medical Advances Cancer Trial, Expands Hemopurifier Study Sites Globally | AEMD Stock News - StockTitan
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Yahoo Finance
Aethlon Medical Reports Progress in Oncology Trials - TipRanks
Aethlon Medical Advances Oncology Trials and Global Expansion - TipRanks
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Kilgore News Herald
Aethlon Medical Launches Groundbreaking Cancer Trial for Hemopurifier Device in Australia | AEMD Stock News - StockTitan
AEMDAETHLON MEDICAL INC Latest Stock News & Market Updates - StockTitan
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer - Medical Device Network
Aethlon Medical Launches Breakthrough Cancer Trial for Hemopurifier® Treatment | AEMD Stock News - StockTitan
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Aethlon Medical (AEMD) Sets Q2 2024 Earnings Release for November 13 | AEMD Stock News - StockTitan
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now - The Manila Times
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Is Aethlon Medical Inc (AEMD) worth investing in despite its overvalued state? - US Post News
Daily Progress: Aethlon Medical Inc (AEMD) Gain 1.15, Closing at 0.40 - The Dwinnex
Aethlon Medical Inc (AEMD) Q1 2025 Earnings Call Highlights: Strategic Cost Management and ... - Yahoo Finance
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit - cnhinews.com
A new trading data show Aethlon Medical Inc (AEMD) is showing positive returns. - SETE News
Deeper Dive: Understanding Aethlon Medical Inc (AEMD) Through its Various Ratios - The Dwinnex
Aethlon Medical names James Frakes permanent CEO By Investing.com - Investing.com Canada
Aethlon Medical names James Frakes permanent CEO - Investing.com
Aethlon Medical Appoints James B. Frakes as CEO - TipRanks
Aethlon Medical Expands Equity Incentive Plan by 3 Million shares - Investing.com Canada
Examining Aethlon Medical Inc (AEMD) stock is warranted - US Post News
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Analysts’ New Coverage for September 29th (AEMD, AEZS, AWX, BGCP, BGI, BLPH, BPTH, CAC, CALA, CBFV) - Defense World
AEMD: Positive Takeaways from Life Science Investor Forum Presentation - Zacks Small Cap Research
Analysts’ New Coverage for September 21st (AEMD, AEZS, AWX, BGCP, BLPH, BPTH, CAC, CALA, CBFV, CCM) - Defense World
Quarterly Metrics: Quick and Current Ratios for Aethlon Medical Inc (AEMD) - The Dwinnex
AEMD’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Market cap of Aethlon Medical Inc [AEMD] reaches 5.44M – now what? - The DBT News
Aethlon Hemopurifier study receives ethics approval in India By Investing.com - Investing.com Nigeria
A look at AEMD’s current quarter earnings estimates - US Post News
Aethlon Hemopurifier study receives ethics approval in India - Investing.com
Immunotherapy Clinical TrialsA New Approach to Treating Cancer - StockTitan
Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India - StockTitan
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Present at Virtual Investor Conferences in September - Investorideas.com newswire
Aethlon Medical to Present at Virtual Investor Conferences in September - StockTitan
Aethlon Medical Inc Azioni (AEMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):